Europe

Novo Nordisk logo on a window
Business Strategy
Novo on the ‘ins and outs’ of its nucleic acid growthNovo on the ‘ins and outs’ of its nucleic acid growth
byDan Stanton
Jan 16, 2025
5 Min Read
Obesity on a board
Investment
Antag bags $84M in series A funding to drive obesity candidate to the clinicAntag bags $84M in series A funding to drive obesity candidate to the clinic
byMillie Nelson
Dec 19, 2024
2 Min Read
Berlin on written wooden block
Innovation
Bayer expands global incubator network with Germany hub
Bayer expands global incubator network with Germany hub
Dec 9, 2024
|
2 Min Read
byMillie Nelson, Editor
The ELA'S 2024
Innovation
LSX awards the crème de la crème of dealmaking
LSX awards the crème de la crème of dealmaking
Dec 3, 2024
|
2 Min Read
byMillie Nelson, Editor
CMO Summit in Milan, Italy
Investment
IPOs on course for recovery but does biotech need public funding anymore?
IPOs on course for recovery but does biotech need public funding anymore?
Nov 12, 2024
|
4 Min Read
byDan Stanton, Editorial director
Seed Funding
Europe’s aversity to risk is why the US is ahead, say experts
Europe’s aversity to risk is why the US is ahead
Nov 5, 2024
|
3 Min Read
byMillie Nelson, Editor

BIO-EUROPE COVERAGE

Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Hubs
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech

Latest

funding round on wooden blocks with dollars behind
Investment
The CAR-T promise: Umoja bags $100m in Series C financing
The CAR-T promise: Umoja bags $100m in Series C financing
Hot keys for business analysis and commercialization
Scaling/Commercialization
A clear commercialization strategy is imperative for success, says expert
A clear commercialization strategy is imperative for success, says expert
The word ONCOLOGY is written on wooden cubes near a stethoscope
Investment
Lilly taking sting out of Scorpion in $2.5bn cancer drug buy
Lilly taking sting out of Scorpion in $2.5bn cancer drug buy
Mar 17 - Mar 19, 2025
Europe's Largest Springtime Biotech Partnering Event
REGISTER
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated